Optimized CRISPR/CAS9 Delivery for Disease Model Generation

Product News   Nov 27, 2015

 
Optimized CRISPR/CAS9 Delivery for Disease Model Generation
 
 
FURTHER INFORMATION
 
 
 

Related Product News

The CRISPR Journal Announces Inaugural Issue Launch

Product News

The CRISPR Journal, a groundbreaking new peer-reviewed journal from Mary Ann Liebert, Inc., publishers, announces the publication of its inaugural issue.

READ MORE

Twist Bioscience Launches Exome and Custom Target Enrichment Solutions for Next-Generation Sequencing

Product News

New product line leverages established DNA synthesis platform to revolutionize exome and custom sequencing.

READ MORE

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE